MARKET

IOVA

IOVA

Iovance Biotherp
NASDAQ
4.250
+0.040
+0.95%
After Hours: 4.240 -0.01 -0.24% 19:57 06/26 EDT
OPEN
4.215
PREV CLOSE
4.210
HIGH
4.410
LOW
4.125
VOLUME
23.72M
TURNOVER
--
52 WEEK HIGH
5.63
52 WEEK LOW
1.660
MARKET CAP
1.90B
P/E (TTM)
-4.4746
1D
5D
1M
3M
1Y
5Y
1D
Mizuho Securities Sticks to Their Buy Rating for Iovance Biotherapeutics (IOVA)
TipRanks · 6d ago
Weekly Report: what happened at IOVA last week (0615-0619)?
Weekly Report · 6d ago
Iovance grants inducement stock options for 140,860 shares at $3.91 each
PUBT · 06/19 21:15
IOVANCE BIOTHERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 06/19 21:15
Iovance Biotherapeutics files automatic mixed securities shelf
TipRanks · 06/18 20:35
Iovance Biotherapeutics Files Prospectus For Offering Mixed Shelf; Terms Undisclosed
Benzinga · 06/18 20:33
IOVANCE BIOTHERAPEUTICS INC FILES FOR MIXED SHELF - SEC FILING
Reuters · 06/18 20:32
IOVANCE BIOTHERAPEUTICS INC: SALE AGREEMENT PROSPECTUS SUPPLEMENT COVERING OFFERING OF UP TO $89.7 MLN COMMON STOCK
Reuters · 06/18 20:32
More
About IOVA
Iovance Biotherapeutics, Inc. is a commercial biotechnology company. The Company is focused on developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. Its products include Amtagvi and Proleukin. Amtagvi is indicated for the treatment of adult patients with melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor, with or without a MEK inhibitor. It is marketing Proleukin (aldesleukin), an interleukin-2 (IL-2) product used in the Amtagvi treatment regimen and in other applications. Amtagvi and Proleukin are part of a treatment regimen that includes lymphodepletion. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings and indications for solid tumor cancers. Its TIL therapy includes melanoma, non-small cell lung cancer and gynecologic cancer.

Webull offers Iovance Biotherapeutics Inc stock information, including NASDAQ: IOVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IOVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IOVA stock methods without spending real money on the virtual paper trading platform.